The cash-strapped federal government’s ability to fund stem-cell research has become severely limited, the top official in charge of the research told attendees at the World Stem Cell Summit on Wednesday. So the private sector is being encouraged to play a larger role, to take over some functions, provide order and reduce needless duplication of effort.
Recent Posts
- Infant becomes world’s first patient to undergo personalized gene-editing treatment
- Biotech Tango dances away from preclinical work to extend cash runway, while Avalo lays out spending options
- Embryonic macrophages found to control blood stem cell numbers in bone marrow
- Federal appeals court sends CRISPR-Cas9 patent case back to patent office for reconsideration
- The stem cell race for Parkinson’s disease: Recent studies show significant promise
- New Cell Therapy For Resistant Hodgkins Patients